Literature DB >> 19902335

Two ply tubular scaffolds comprised of proteins/poliglecaprone/polycaprolactone fibers.

Xing Zhang1, Vinoy Thomas, Yogesh K Vohra.   

Abstract

Electrospun bi-layer tubular hybrid scaffolds composed of poliglecaprone (PGC), polycaprolactone (PCL), elastin (E), and gelatin (G) were prepared and thereafter crosslinked by 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC). Scanning electron microscopic (SEM) images revealed a highly porous micro-structure comprising randomly distributed non-woven fibers with the majority of fibers in submicron diameters. The EDC-crosslinking yielded an average crosslinking degree of 40%. Uni-axial tensile test of hydrated scaffolds in both longitudinal and circumferential directions revealed tensile properties, comparable to those of native arteries. The graft (PGC:PCL = 1:3) did not demonstrate significant difference before and after EDC-crosslinking in tensile strength or % strain in either longitudinal or circumferential directions. However, crosslinking increased the Young's modulus of the graft along the longitudinal direction (from 5.84 to 8.67 MPa). On the contrary, the graft (3:1) demonstrated a significant decrease in maximum strain in both directions. Cyto-assay using human umbilical vein endothelial cells (HUVECs) showed excellent cell viability.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19902335     DOI: 10.1007/s10856-009-3922-y

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  29 in total

1.  Co-electrospun poly(lactide-co-glycolide), gelatin, and elastin blends for tissue engineering scaffolds.

Authors:  Mengyan Li; Mark J Mondrinos; Xuesi Chen; Milind R Gandhi; Frank K Ko; Peter I Lelkes
Journal:  J Biomed Mater Res A       Date:  2006-12-15       Impact factor: 4.396

2.  Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects.

Authors:  J S Pieper; T Hafmans; J H Veerkamp; T H van Kuppevelt
Journal:  Biomaterials       Date:  2000-03       Impact factor: 12.479

Review 3.  Tissue-engineered blood vessels: alternative to autologous grafts?

Authors:  Michel R Hoenig; Gordon R Campbell; Barbara E Rolfe; Julie H Campbell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-10       Impact factor: 8.311

Review 4.  Nanofiber technology: designing the next generation of tissue engineering scaffolds.

Authors:  Catherine P Barnes; Scott A Sell; Eugene D Boland; David G Simpson; Gary L Bowlin
Journal:  Adv Drug Deliv Rev       Date:  2007-08-25       Impact factor: 15.470

Review 5.  Electrospinning: applications in drug delivery and tissue engineering.

Authors:  Travis J Sill; Horst A von Recum
Journal:  Biomaterials       Date:  2008-02-20       Impact factor: 12.479

6.  In vitro biodegradation of designed tubular scaffolds of electrospun protein/polyglyconate blend fibers.

Authors:  Xing Zhang; Vinoy Thomas; Yogesh K Vohra
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2009-04       Impact factor: 3.368

7.  Functionally graded electrospun scaffolds with tunable mechanical properties for vascular tissue regeneration.

Authors:  Vinoy Thomas; Xing Zhang; Shane A Catledge; Yogesh K Vohra
Journal:  Biomed Mater       Date:  2007-10-08       Impact factor: 3.715

Review 8.  Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices.

Authors:  A Jayakrishnan; S R Jameela
Journal:  Biomaterials       Date:  1996-03       Impact factor: 12.479

Review 9.  Methods for the treatment of collagenous tissues for bioprostheses.

Authors:  E Khor
Journal:  Biomaterials       Date:  1997-01       Impact factor: 12.479

10.  Electrospinning of novel biodegradable poly(ester urethane)s and poly(ester urethane urea)s for soft tissue-engineering applications.

Authors:  Pablo C Caracciolo; Vinoy Thomas; Yogesh K Vohra; Fabián Buffa; Gustavo A Abraham
Journal:  J Mater Sci Mater Med       Date:  2009-05-12       Impact factor: 3.896

View more
  12 in total

1.  A hybrid biomimetic nanomatrix composed of electrospun polycaprolactone and bioactive peptide amphiphiles for cardiovascular implants.

Authors:  Adinarayana Andukuri; Meenakshi Kushwaha; Ajay Tambralli; Joel M Anderson; Derrick R Dean; Joel L Berry; Young Doug Sohn; Young-Sup Yoon; Brigitta C Brott; Ho-Wook Jun
Journal:  Acta Biomater       Date:  2010-08-20       Impact factor: 8.947

2.  Elastin-based biomaterials and mesenchymal stem cells.

Authors:  Jazmin Ozsvar; Suzanne M Mithieux; Richard Wang; Anthony S Weiss
Journal:  Biomater Sci       Date:  2015-06       Impact factor: 6.843

3.  Mechanical property characterization of electrospun recombinant human tropoelastin for vascular graft biomaterials.

Authors:  Kathryn A McKenna; Monica T Hinds; Rebecca C Sarao; Ping-Cheng Wu; Cheryl L Maslen; Robert W Glanville; Darcie Babcock; Kenton W Gregory
Journal:  Acta Biomater       Date:  2011-08-06       Impact factor: 8.947

4.  Biohybrid Fibro-Porous Vascular Scaffolds: Effect of Crosslinking on Properties.

Authors:  Vinoy Thomas; Danna Nozik; Harsh Patel; Raj K Singh; Yogesh K Vohra
Journal:  Mater Res Soc Symp Proc       Date:  2015

Review 5.  Fabricated Elastin.

Authors:  Behnaz Aghaei-Ghareh-Bolagh; Edwin P Brackenreg; Matti A Hiob; Pearl Lee; Giselle C Yeo; Anthony S Weiss
Journal:  Adv Healthc Mater       Date:  2015-03-13       Impact factor: 9.933

6.  Fibro-porous poliglecaprone/polycaprolactone conduits: synergistic effect of composition and in vitro degradation on mechanical properties.

Authors:  Harsh N Patel; Roman Garcia; Carrie Schindler; Derrick Dean; Steven M Pogwizd; Raj Singh; Yogesh K Vohra; Vinoy Thomas
Journal:  Polym Int       Date:  2015-04       Impact factor: 2.990

7.  A tissue-engineered subcutaneous pancreatic cancer model for antitumor drug evaluation.

Authors:  Qingyi He; Xiaohui Wang; Xing Zhang; Huifang Han; Baosan Han; Jianzhong Xu; Kanglai Tang; Zhiren Fu; Hao Yin
Journal:  Int J Nanomedicine       Date:  2013-03-19

8.  Drug-eluting scaffold to deliver chemotherapeutic medication for management of pancreatic cancer after surgery.

Authors:  Qian Zhan; Baiyong Shen; Xiaxing Deng; Hao Chen; Jiabin Jin; Xing Zhang; Chenghong Peng; Hongwei Li
Journal:  Int J Nanomedicine       Date:  2013-07-11

9.  The therapeutic effect of monocyte chemoattractant protein-1 delivered by an electrospun scaffold for hyperglycemia and nephrotic disorders.

Authors:  Cai Yong; Zhengxin Wang; Xing Zhang; Xiaomin Shi; Zhijia Ni; Hong Fu; Guoshan Ding; Zhiren Fu; Hao Yin
Journal:  Int J Nanomedicine       Date:  2014-02-17

10.  The therapeutic role of monocyte chemoattractant protein-1 in a renal tissue engineering strategy for diabetic patients.

Authors:  Hao Yin; Ming Gao; Lara Leoni; Huifang Han; Xing Zhang; Zhiren Fu
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.